Literature DB >> 33340501

Deciphering Melanoma Cell States and Plasticity with Zebrafish Models.

Jana Travnickova1, E Elizabeth Patton2.   

Abstract

Dynamic cellular heterogeneity underlies melanoma progression and therapy resistance. Advances in single-cell technologies have revealed an increasing number of tumor and microenvironment cell states in melanoma, but little is understood about their function in vivo. Zebrafish models are a powerful system for discovery, live imaging, and functional investigation of cell states throughout melanoma progression and treatment. By capturing dynamic melanoma states in living animals, zebrafish have the potential to resolve the complexity of melanoma heterogeneity from a single cell through disease processes within the context of the whole body, revealing novel cancer biology and therapeutic targets.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33340501     DOI: 10.1016/j.jid.2020.12.007

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

Review 1.  The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval.

Authors:  Mariana Matias; Jacinta O Pinho; Maria João Penetra; Gonçalo Campos; Catarina Pinto Reis; Maria Manuela Gaspar
Journal:  Cells       Date:  2021-11-09       Impact factor: 6.600

2.  Fate mapping melanoma persister cells through regression and into recurrent disease in adult zebrafish.

Authors:  Jana Travnickova; Sarah Muise; Sonia Wojciechowska; Alessandro Brombin; Zhiqiang Zeng; Adelaide I J Young; Cameron Wyatt; E Elizabeth Patton
Journal:  Dis Model Mech       Date:  2022-09-16       Impact factor: 5.732

Review 3.  The Zebrafish model in dermatology: an update for clinicians.

Authors:  Irene Russo; Emma Sartor; Laura Fagotto; Natascia Tiso; Mauro Alaibac; Anna Colombo
Journal:  Discov Oncol       Date:  2022-06-17

Review 4.  Melanoma models for the next generation of therapies.

Authors:  E Elizabeth Patton; Kristen L Mueller; David J Adams; Niroshana Anandasabapathy; Andrew E Aplin; Corine Bertolotto; Marcus Bosenberg; Craig J Ceol; Christin E Burd; Ping Chi; Meenhard Herlyn; Sheri L Holmen; Florian A Karreth; Charles K Kaufman; Shaheen Khan; Sebastian Kobold; Eleonora Leucci; Carmit Levy; David B Lombard; Amanda W Lund; Kerrie L Marie; Jean-Christophe Marine; Richard Marais; Martin McMahon; Carla Daniela Robles-Espinoza; Ze'ev A Ronai; Yardena Samuels; Maria S Soengas; Jessie Villanueva; Ashani T Weeraratna; Richard M White; Iwei Yeh; Jiyue Zhu; Leonard I Zon; Marc S Hurlbert; Glenn Merlino
Journal:  Cancer Cell       Date:  2021-02-04       Impact factor: 31.743

5.  Long-term non-invasive drug treatments in adult zebrafish that lead to melanoma drug resistance.

Authors:  Yuting Lu; E Elizabeth Patton
Journal:  Dis Model Mech       Date:  2022-05-09       Impact factor: 5.732

6.  Tfap2b specifies an embryonic melanocyte stem cell that retains adult multifate potential.

Authors:  Alessandro Brombin; Daniel J Simpson; Jana Travnickova; Hannah Brunsdon; Zhiqiang Zeng; Yuting Lu; Adelaide I J Young; Tamir Chandra; E Elizabeth Patton
Journal:  Cell Rep       Date:  2022-01-11       Impact factor: 9.423

7.  Aldh2 is a lineage-specific metabolic gatekeeper in melanocyte stem cells.

Authors:  Hannah Brunsdon; Alessandro Brombin; Samuel Peterson; John H Postlethwait; E Elizabeth Patton
Journal:  Development       Date:  2022-05-19       Impact factor: 6.862

Review 8.  Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials.

Authors:  E Elizabeth Patton; Leonard I Zon; David M Langenau
Journal:  Nat Rev Drug Discov       Date:  2021-06-11       Impact factor: 112.288

Review 9.  Zebrafish as a Neuroblastoma Model: Progress Made, Promise for the Future.

Authors:  Shuai Li; Kok Siong Yeo; Taylor M Levee; Cassie J Howe; Zuag Paj Her; Shizhen Zhu
Journal:  Cells       Date:  2021-03-06       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.